Crataeva nurvala: A valuable medicinal plant

Journal of Herbs, Spices and Medicinal Plants

Volumn 14, Issue 1-2, 2008, Pages 107-127

  Bopana, Nishritha ^a   Saxena, Sanjay ^b  

^a TERI UNIVERSITY   (India)

^b THE ENERGY AND RESOURCES INSTITUTE   (India)

Author keywords

Antiarthritic activity; Cardioprotective; Conservation; Hepatoprotective; Lupeol; Medicinal plant; Micropropagation; Nephroprotective; Traditional medicine; Urinary disorders

Indexed keywords

3 EPILUPEOL; ALCOHOL DERIVATIVE; ALPHA SPINASTEROL; ANTIBIOTIC AGENT; BETULIN; CADABICINE; CADABICINE DIACETATE; CISPLATIN; CRATAEVA NURVALA EXTRACT; CYCLOPHOSPHAMIDE; FUROSEMIDE; HERBACEOUS AGENT; HIMPLASIA; INDOMETACIN; LUPEOL; LUPEOL ACETATE; LUPEOL LINOLEATE; PLANT EXTRACT; PR 2000; RENALKA; SITOSTEROL; TARAXASTEROL; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; URIFLOW;

DEFORESTATION; GERMINATION; HARVESTING; MEDICINAL PLANT; SEMIARID REGION;

ABSENCE OF SIDE EFFECTS; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; BARK; CLINICAL TRIAL; CRATAEVA NURVALA; CYSTITIS; DEFORESTATION; DRUG FORMULATION; DYSURIA; ENVIRONMENTAL FACTOR; GERMINATION; HABITAT; HEART PROTECTION; HEMATURIA; HUMAN; HYPEROXALURIA; INDIA; KIDNEY TUBULE DAMAGE; LIVER PROTECTION; MALARIA; MEDICINAL PLANT; MICTURITION DISORDER; NEPHROLITHIASIS; NONHUMAN; PATENT; PLANT ROOT; PROSTATE HYPERTROPHY; RECURRENT DISEASE; RENAL PROTECTION; REVIEW; RHEUMATOID ARTHRITIS; SURVIVAL; TRADITIONAL MEDICINE; URINARY TRACT DISEASE; URINARY TRACT INFECTION; UROLITHIASIS; WORLD HEALTH ORGANIZATION;

CAPPARACEAE; CRATAEVA NURVALA;

EID: 67749130731     PISSN: 10496475     EISSN: 15403580     Source Type: Journal    
DOI: 10.1080/10496470802341532     Document Type: Review

References (47)

1. Agarwal, R.B. and V.D. Rangari. 2003. Antiinflammatory and antiarthritic activities of lupeol and 19α-H lupeol isolated from Strobilanthus callosus and Strobilanthus ixiocephala roots. Indian J. Pharmacol. 35:384-387.
2. Ahmad, V.U., K. Fizza, A.R. Amber and S. Arif. 1987.Cadabicine and cadabicine diacetate from Crataeva nurvala and Cadaba farinosa. J. Nat. Prod. 50(6):1186.
3. Anand, R, G.K. Patnaik, D.K. Kulshreshtha and B.N. Dhawan. 1994. Antiurolithiatic activity of lupeol, the active constituent isolated from Crataeva nurvala. Phytother. Res. 8:417-421.
4. Anonymous. 1987. Crataeva. Wealth of India, vol. 2. CSIR Publications, New Delhi. 366 p.
5. Arora, R.P., R.L. Nayak, V. Malhotra, N.K. Mohanty and K.S. Kulkarni. 2003. Role of herbal drugs in the management of benign prostatic hyperplasia: Clinical trials to evaluate the efficacy and safety of Himplasia. Med. Update 11(2):55-58.
6. Benniamin, A., V.S. Manickam, M. Johnson and L.H. Joseph. 2004. Micropropaga-tion of Crataeva magna (Lour.) DC. - a medicinal plant. Indian J. Biotechnol. 3:136-138.
7. Bopana, N. and S. Saxena. 2007. Asparagus racemosus - Ethnopharamacological evaluation and conservation needs. J. Ethnopharmacol. 110:1-15.
8. Chakraborty, S., D. Karmakar and S.A. Kolhapure. 2004. Evaluation of the efficacy and safety of Himplasia in BPH: A randomised, double-blind, placebo-controlled, phase III clinical trial. http://www.himalayhealthcare.com/ pdf-files/himplasia010.pdf. Accessed on 28/12/2005.
9. Deshpande, P.J., M. Sahu and P. Kumar. 1982. Crataeva nurvala Hook and Forst (Varuna)- the Ayurvedic drug of choice in urinary disorders. Indian J Med Res. 76:46-53.
10. FRLHT's Encyclopedia of Indian Medicinal Plants. Plant profile Crataeva nurvala, No. 625. http://www.frlht.org.in/meta. Accessed on 3/01/06.
11. Fukusaki, E. and A. Kobayashi. 2005. Plant Metabolomics: Potential for practical application. J Biosci. Bioengin. 100(4):347-354.
12. Geetha, T. and P. Varalakshmi. 1999. Anticomplement activity of triterpenes from Crataeva nurvala stem bark in adjuvant arthritis in rats. Gen. Pharmacol. 32:495-497.
13. Geetha, T. and P. Varalakshmi. 2001. Anti-inflammatory activity of lupeol and lupeol linoleate in rats. J. Ethnopharmacol. 76:77-80.
14. Geetha, T., P. Varalakshmi, and R.M. Latha. 1998.Effect of triterpenes from Crataeva nurvala stem bark on lipid peroxidation in adjuvant induced arthritis in rats. Pharmacol Res. 37(3):191-195.
15. Himalaya Herbal Healthcare: Renalka Accessed on 12/28/2005.
16. Holley, J. and K. Cherla. 1998. The Medicinal Plants Sector in India. Medicinal and Aromatic Plants Program in Asia (MAPPA). The International Development Research Center (IDRC), Ottawa. 25 p.
17. Kumar, A., A.K. Gupta, B.G. Marcot, A. Saxena, S.P. Singh and T.T.C. Marak. 2002. Management of Forests in India for Biological Diversity and Forest Productivity: A New Perspective, vol. IV. Wildlife Institute of India (WII)-United States Department of Agriculture Forest Service Collaborative Project, Dehra Dun, India.
18. Lakshmi, V. and J.S. Chauhan. 1977. A new pentacyclic triterpene from the root bark of Crataeva nurvala. Planta Med. 32:214-216.
19. Latha, R.M., M. Lenin, M. Rasool and P. Varalakshmi. 2001. A novel derivative pentacyclic triterpene and ω 3 fatty acid [Lupeol-EPA] in relation to lysosomal enzymes glycoproteins and collagen in adjuvant induced arthritis in rats. Prostagland. Leukotrien. Essential Fatty Acids 64(2):81-85.
20. Malini, M.M., M. Lenin and P. Varalakshmi. 2000. Protective effect of triterpenes on calcium oxalate crystal-induced peroxidative changes in experimental urolithiasis. Pharmacol. Res. 41(4):413-418.
21. Malini, M.M., R. Baskar and P. Varalakshmi. 1995. Effect of lupeol, a pentacyclic triterpene, on urinary enzymes in hyperoxaluric rats. Jpn. J. Med. Sci. Biol. 48(5-6): 211-220.
22. McLean, W.F.H., G. Blunden and K. Jewers. 1996. Quaternary ammonium compounds in the Capparaceae. Biochem. System. Ecol. 24(5):427-434.
23. Meher, S.K., S.B. Chaudhuri, B. Marjit, P.K. Mukherjee, A.K. Ram, S. Munshi, N. Das, K.K. Kundu, C.N. Islam and A.K. Das. 2001. Nephroprotective action of Tribulus terrestris Linn and Crataeva nurvala Buch-Ham in albino rats [Abstract]. XXXIII Annual Conference of the Indian Pharmacological Society, Gandhinagar, December 28-30, 2000. Indian J. Pharmacol. 33:128.
24. Mhaskar, K.S., F. Blatter and J.F. Caius, eds. 2000. Kirtikar and Basu's Illustrated Indian Medicinal Plants: Their usage in Ayurveda and Unani medicines, 3rd rev., vol. 1. Sri Satguru Publications, New Delhi. pp. 254-259.
25. Modi, P.R. and S.A. Kohlapure. 2004. Evaluation of clinical efficacy and safety of Himplasia in BPH: A prospective, randomized, placebo-controlled, double blind, phase III clinical trial. Med. Update. 12(6):33-42.
26. Oneal, J. and G. White. 2004. Method and composition for maintaining urinary tract health in the face of infections. Patent number: US2004147459. http://scientific. thomsonreuters.com/media/scpdf/patentspreview-sample.pdf. Accessed in 2006.
27. Sahu, M., R.P. Bhat and K.S. Kulkarni. 2003. Clinical evaluation of Himplasia in benign prostaic hyperplasia: An open clinical trial. Med. Update 11(1):75-78.
28. Samiulla, D.S. and M.S. Harish. 2000. Effect of NR-AG-I and NR-AG-II (polyherbal formulations) on diuretic activity in rat. Indian J. Pharmacol. 32:112-113.
29. Shirwaikar, A., M. Setty, P. Bommu and B. Krishnanand. 2004. Ethanol extract of Crataeva nurvala stem bark reverses Cisplatin-induced Nephrotoxicity. Pharmaceut. Biol. 42(7):559-564.
30. Shukla, G.N. and M. Nayak. 2002. Use of PR-2000, a herbal formulation in the medical management of benign prostatic hyperplasia. Indian J. Clin. Pract. 13(2):53-56.
31. Shukla, K. and S.A. Kohlapure. 2004. Evaluating the efficacy and safety of Himplasia (PC-27) in the medical management of benign hyperplasia. Indian J. Clin. Pract. 14(11):31-36.
32. Srinivasan, T., G.K. Srivastava, A. Pathak, S. Batra, K. Raj, K. Singh, S.K. Puri and B. Kundu. 2002. Solid-phase synthesis and bioevaluation of lupeol-based libraries as antimalarial agents. Bioorg. Med. Chem. Lett. 12:2803-2806.
33. Sudhahar, V., S.A. Kumar and P. Varalakshmi. 2005. Role of lupeol and lupeol linoleate on lipemic-oxidative stress in experimental hypercholesterolemia. Clin. Chim. Acts 355:119-130.
34. Sudharsan, P.T., Y. Mythili, E. Selvakumar and P. Varalakshmi P.2005. Cardioprotective effect of pentacyclic triterpene, lupeol and its ester on cyclophosphamide-induced oxidative stress. Hum. Exp. Toxicol. 24(6):313-318.
35. Sudharsan, P.T., Y. Mythili, E. Selvakumar and P. Varalakshmi. 2006. Lupeol and its ester ameliorate the cyclophosphamide provoked cardiac lysosomal damage studied in rat. Mol. Cell. Biochem. 282(1-2):23-29.
36. Sudharsan, P.T., Y. Mythili, V. Sudhahar and P. Varalakshmi. 2005. Role of lupeol and its ester on cyclophosphamide-induced hyperlipidaemic cardiomyopathy in rats. J. Pharm. Pharmacol. 57(11):1437-1444.
37. Sunitha, S., M. Nagraj and P. Varalakshmi. 2001. Hepatoprotective effect of lupeol and lupeol linoleate on tissue antioxidant defence system in cadmium-induced hepatotoxicity in rats. Fitoterapia 72:516-523.
38. Suthar, A.C., M.M. Banavalikar, M.K. Biyani, P.K. Indira, V. Sudarsan and H. Mohan. 2001. A high performance thin layer chromatography method for quantitative estimation of lupeol in Crataeva nurvala. Indian Drugs 38(9):474-478.
39. Uriflow.com. 2005. http://www.getridofkidneystones.com/clinical-proof. html. Accessed on 3/12/05.
40. Varalakshmi, P., E. Latha, Y. Shamila and S. Jayanthi. 1991. Effect of Crataeva nurvala on the biochemistry of the small intestinal tract of normal and stone forming rats. J. Ethnopharmacol. 31:67-73.
41. Varalakshmi, P., Y. Shamila and E. Latha. 1990. Effect of Crataeva nurvala in experimental urolithiasis. J. Ethnopharmacol. 28:313-321.
42. Vidya, L. and P. Varalakshmi. 2000. Control of urinary risk factors of stones by betulin and lupeol in experimental hyperoxaluria. Fitoterapia 71:535-543.
43. Vidya, L., M. Lenin and P. Varalakshmi P. 2002. Evaluation of the effect of triterpenes on urinary risk factors of stone formation in pyridoxine deficient hyperoxaluric rats. Phytother. Res. 16(6):514-518.
44. Vidya, L., M.M. Malini and P. Varalakshmi. 2000. Effect of pentacyclic triterpe-nes on oxalate-induced changes in rat erythrocytes. Pharmacol. Res. 42(4):313-316.
45. Vijai Lakshmi and J.S. Chauhan. 1975. Triterpenoids and related compounds from Crataeva nurvala. Plant Med. 27:254-256.
46. Warrier, P.K., V.P.K. Nambiar and C. Ramankutty. 1994. Crataeva magna (Lour.) DC. Indian Medicinal Plants: A Compendium of 500 Species, vol. 2. Orient Longman Ltd, Madras.
47. World Health Organization. Traditional Medicine. Fact sheet 134. Geneva. http:// www.who.int/mediacentre/factsheet/fs134/en/ Accessed on 7/115/05.